Lowest-Rated StocksLowest-RatedNASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free DOCS Stock Alerts $23.82 +0.23 (+0.97%) (As of 05:27 PM ET) Add Compare Share Share Today's Range$23.54▼$24.1050-Day Range$23.59▼$30.3352-Week Range$19.71▼$36.92Volume874,462 shsAverage Volume1.74 million shsMarket Capitalization$4.44 billionP/E Ratio36.09Dividend YieldN/APrice Target$28.82 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Get Doximity alerts: Email Address Doximity MarketRank™ Stock AnalysisAnalyst RatingHold2.07 Rating ScoreUpside/Downside21.0% Upside$28.82 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 27 Articles This WeekInsider TradingSelling Shares$67,425 Sold Last QuarterProj. Earnings Growth6.94%From $0.72 to $0.77 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.44 out of 5 starsMedical Sector311th out of 908 stocksCustom Computer Programming Services Industry11th out of 23 stocks 3.0 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on 2 buy ratings, 11 hold ratings, and 1 sell rating.Amount of Analyst CoverageDoximity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 3.1 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Doximity this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.MarketBeat Follows12 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 71% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $67,425.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 6.94% in the coming year, from $0.72 to $0.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 36.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.65.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 36.09, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 187.42.Price to Earnings Growth RatioDoximity has a PEG Ratio of 3.01. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 4.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Doximity Stock (NASDAQ:DOCS)Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesApril 3, 2024 | insidertrades.comKira Scherer Wampler Sells 2,500 Shares of Doximity, Inc. (NASDAQ:DOCS) StockApril 26, 2024 | markets.businessinsider.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 26, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) InvestorsApril 26, 2024 | msn.comJP Morgan Upgrades Doximity (DOCS)April 25, 2024 | tmcnet.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) InvestorsApril 25, 2024 | businesswire.comDoximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024April 24, 2024 | markets.businessinsider.comDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors Can Join the Class Action LawsuitApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 24, 2024 | americanbankingnews.comDoximity (NASDAQ:DOCS) Receives Underweight Rating from Morgan StanleyApril 24, 2024 | prnewswire.comDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!April 23, 2024 | businesswire.comDOCS INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCSApril 23, 2024 | prnewswire.comIMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmApril 23, 2024 | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoximityApril 22, 2024 | markets.businessinsider.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmApril 22, 2024 | tmcnet.comDoximity, Inc. (DOCS) Investor Notice: Robbins LLP Reminds Stockholders of the Doximity, Inc. Shareholder Class ActionApril 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCSApril 21, 2024 | americanbankingnews.comDoximity, Inc. (NASDAQ:DOCS) Given Consensus Rating of "Hold" by AnalystsApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCSApril 20, 2024 | prnewswire.comDOCS Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Doximity, Inc. (DOCS) that a Securities Fraud Class Action Lawsuit Has Been Filed On Their BehalfApril 20, 2024 | stockhouse.comDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors Can Join the Class Action Lawsuit!April 19, 2024 | businesswire.comDOXIMITY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSApril 19, 2024 | markets.businessinsider.comSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmApril 19, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) InvestorsApril 18, 2024 | markets.businessinsider.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Doximity, Inc. (DOCS)April 17, 2024 | businesswire.comInvestor Alert: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Doximity, Inc. and Encourages Investors With Losses to Contact the Firm (NYSE: DOCS)April 16, 2024 | americanbankingnews.comAnalyzing TruBridge (NASDAQ:TBRG) and Doximity (NASDAQ:DOCS)See More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2024Today4/26/2024Next Earnings (Confirmed)5/16/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryN/A Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees977Year FoundedN/APrice Target and Rating Average Stock Price Target$28.82 High Stock Price Target$33.00 Low Stock Price Target$23.00 Potential Upside/Downside+20.6%Consensus RatingHold Rating Score (0-4)2.07 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)$0.66 Trailing P/E Ratio36.20 Forward P/E Ratio33.18 P/E Growth3.01Net Income$112.82 million Net Margins29.39% Pretax Margin37.15% Return on Equity16.08% Return on Assets13.76% Debt Debt-to-Equity RatioN/A Current Ratio8.03 Quick Ratio8.03 Sales & Book Value Annual Sales$419.05 million Price / Sales10.64 Cash Flow$0.72 per share Price / Cash Flow33.28 Book Value$4.98 per share Price / Book4.80Miscellaneous Outstanding Shares186,550,000Free Float113,052,000Market Cap$4.46 billion OptionableNot Optionable Beta1.17 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Jeffrey A. Tangney (Age 51)Co-Founder, CEO & Chairperson Comp: $243.73kDr. Nate Gross M.D. (Age 40)Co-Founder & Chief Strategy Officer Comp: $455.54kMs. Anna Bryson (Age 34)Chief Financial Officer Comp: $453.71kMs. Jennifer W. Chaloemtiarana (Age 56)General Counsel & Corporate Secretary Comp: $504.04kMr. Paul Jorgensen (Age 53)Chief Revenue Officer Comp: $455.13kMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsJim RivasHead of Corporate CommunicationsMr. Bruno MirandaSenior VP of EngineeringMore ExecutivesKey CompetitorsKrystal BiotechNASDAQ:KRYSBridgeBio PharmaNASDAQ:BBIOFive9NASDAQ:FIVNOrganon & Co.NYSE:OGNLantheusNASDAQ:LNTHView All CompetitorsInsiders & InstitutionsTritonpoint Wealth LLCSold 19,562 shares on 4/26/2024Ownership: 0.001%New York State Teachers Retirement SystemBought 1,531 shares on 4/25/2024Ownership: 0.048%Shaker Investments LLC OHBought 75,355 shares on 4/25/2024Ownership: 0.040%Equitable Trust Co.Bought 2,381 shares on 4/25/2024Ownership: 0.006%Newbridge Financial Services Group Inc.Sold 2,385 shares on 4/24/2024Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Doximity stock right now? 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 1 sell rating, 11 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares. View DOCS analyst ratings or view top-rated stocks. What is Doximity's stock price target for 2024? 14 brokerages have issued twelve-month target prices for Doximity's stock. Their DOCS share price targets range from $23.00 to $33.00. On average, they predict the company's share price to reach $28.82 in the next twelve months. This suggests a possible upside of 21.0% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Doximity's stock was trading at $28.04 at the beginning of the year. Since then, DOCS stock has decreased by 15.0% and is now trading at $23.82. View the best growth stocks for 2024 here. When is Doximity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 16th 2024. View our DOCS earnings forecast. How can I listen to Doximity's earnings call? Doximity will be holding an earnings conference call on Thursday, May 16th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.06. The firm earned $135.28 million during the quarter, compared to analyst estimates of $127.46 million. Doximity had a net margin of 29.39% and a trailing twelve-month return on equity of 16.08%. What ETFs hold Doximity's stock? ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Jacob Forward ETF (JFWD), Janus Henderson Small Cap Growth Alpha ETF (JSML), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Renaissance IPO ETF (IPO), Pacer US Large Cap Cash Cows Growth Leaders ETF (COWG) and SPDR FactSet Innovative Technology ETF (XITK). What guidance has Doximity issued on next quarter's earnings? Doximity updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $473.3 million-$474.3 million, compared to the consensus revenue estimate of $467.3 million. When did Doximity IPO? Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's stock is owned by a number of institutional and retail investors. Top institutional investors include Rice Hall James & Associates LLC (0.42%), New York State Teachers Retirement System (0.05%), Shaker Investments LLC OH (0.04%), Renaissance Capital LLC (0.04%), Amalgamated Bank (0.04%) and Apella Capital LLC (0.03%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DOCS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
